Free Republic
Browse · Search
News/Activism
Topics · Post Article

To: Nachum

Even the most cursory glance at the article should tell you that this has absolutely nothing to do with death panels, Obamacare, or NHS rationing or any of the usual evils, but is the result of an accident at the factory in which the drug is made.

What I want to know is, why is there only one factory in the whole wide world that makes this vital drug? This is a major logistical weakness...


2 posted on 07/11/2012 9:34:52 AM PDT by sinsofsolarempirefan
[ Post Reply | Private Reply | To 1 | View Replies ]


To: sinsofsolarempirefan; Nachum

If people only knew how MANY life-saving/preserving drugs were on a razor’s edge, they’d be very astounded. Flu vaccines, etc have production throughput limitations and single point of failure vulnerabilities that are frightening.


4 posted on 07/11/2012 9:52:36 AM PDT by SargeK
[ Post Reply | Private Reply | To 2 | View Replies ]

To: sinsofsolarempirefan
reading a bit closer it says “But Sanofi Pastuer, which makes the most widely-used product, called Immunocyst, does not expect production to restart before late 2013,” they are not the only makers of BCG
5 posted on 07/11/2012 9:53:43 AM PDT by jrd (DO AWAY WITH THE EPA)
[ Post Reply | Private Reply | To 2 | View Replies ]

Free Republic
Browse · Search
News/Activism
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson